Scale
Reliable Partnerships for the Unknown
We are a preclinical specialized company that can take your drug from drug discovery through to IND submission and into humans with more than twenty years of experience and tens of thousands of clients across the globe.
Drug Discovery is an uncertain journey. ChemPartner’s unique scale and flexibility makes that journey clearer, offering faster pathways to breakthroughs that matter. Two decades of sponsor-grade delivery.
We have more than two decades of expertise, working with tens of thousands of clients to elevate their work and help them take their next big leap forward.
Collaboration
We believe that every one of our clients deserves to be at the front of the line. We put people over process—our team becomes your team, working side-by-side, and bench-to-bench.
Expertise
We have more than 2,000 scientists who are leading authorities in their respective fields, offering an unrivaled, end-to-end client experience with offers and expertise across the entire drug discovery journey.
ChemPartner supports strategic decision-making and day-to-day precision discovery.
Small Molecule
Biologics
Whether you're developing a small molecule, a complex biologic, or navigating the road to IND, ChemPartner has modular, phase-aligned services to deliver results faster and more accurately, with a dedicated team to make sure your project is always at the front of the line.
Click on a stage in the drug development journey to see our capabilities at each stage.
Concept
Target ID
Target Validation
Disease Mechanism
Discovery
Hit to Lead
Lead Optimization
and Characterization
POC Selection
CMC
IND Enabling
CDMO
Commercial
Production
Concept
Target ID
Target Validation
Disease Mechanism
Discovery
Characterization
and Optimization
Lead Optimization
and Characterization
POC Selection
CMC
IND Enabling
CDMO
Commercial
Production
THERAPEUTIC MODALITIES
DISCOVERY CHEMISTRY
TRANSLATIONAL BIOLOGY
THERAPEUTIC MODALITIES
DISCOVERY CHEMISTRY
TRANSLATIONAL BIOLOGY
THERAPEUTIC MODALITIES
DISCOVERY CHEMISTRY
TRANSLATIONAL BIOLOGY
THERAPEUTIC MODALITIES
DISCOVERY CHEMISTRY
TRANSLATIONAL BIOLOGY
THERAPEUTIC MODALITIES
DISCOVERY CHEMISTRY
TRANSLATIONAL BIOLOGY
THERAPEUTIC MODALITIES
DISCOVERY CHEMISTRY
TRANSLATIONAL BIOLOGY
THERAPEUTIC MODALITIES
DISCOVERY CHEMISTRY
TRANSLATIONAL BIOLOGY
THERAPEUTIC MODALITIES
BIOLOGICS DISCOVERY
BIOPROCESS DEVELOPMENT
BIOPROCESS DEVELOPMENT
THERAPEUTIC MODALITIES
BIOLOGICS DISCOVERY
TRANSLATIONAL BIOLOGY
BIOPROCESS DEVELOPMENT
THERAPEUTIC MODALITIES
BIOLOGICS DISCOVERY
TRANSLATIONAL BIOLOGY
BIOPROCESS DEVELOPMENT
THERAPEUTIC MODALITIES
BIOLOGICS DISCOVERY
TRANSLATIONAL BIOLOGY
BIOPROCESS DEVELOPMENT
THERAPEUTIC MODALITIES
BIOLOGICS DISCOVERY
TRANSLATIONAL BIOLOGY
BIOPROCESS DEVELOPMENT
THERAPEUTIC MODALITIES
BIOLOGICS DISCOVERY
TRANSLATIONAL BIOLOGY
BIOPROCESS DEVELOPMENT
THERAPEUTIC MODALITIES
BIOLOGICS DISCOVERY
TRANSLATIONAL BIOLOGY
BIOPROCESS DEVELOPMENT
Small Molecule
Biologics
Our Expertise.
Your Results.
Preclinical Performance
Scale
Publishing
50+
ADME case studies
13
PK/PD toxicology
case studies
90%
USA FDA submission supported
10K+
clients across the globe
8
global locations across 3 continents
2000+
scientists on the bench
100K+
ADME case studies
10K+
PK/PD toxicology
case studies
400+
USA FDA submission supported
Preclinical Performance
Scale
Publishing
Our Work
Drug Discovery is unpredictable. We make it inevitable.
“Our R&D success today would be impossible without the excellent work of collaboration partners like ChemPartners.”
-DR. LI CHEN, CHIEF SCIENTIFIC OFFICER, ROCHE R&D